{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:02:14Z","timestamp":1784739734773,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.lungcan.2004.02.021","type":"journal-article","created":{"date-parts":[[2004,6,12]],"date-time":"2004-06-12T16:41:09Z","timestamp":1087058469000},"page":"325-337","source":"Crossref","is-referenced-by-count":48,"title":["Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs)"],"prefix":"10.1016","volume":"45","author":[{"given":"Haruhiko","family":"Ishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Yazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanako","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaichi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Takanashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2004.02.021_BIB1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/er.18.1.4","article-title":"The biology of vascular endothelial growth factor","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.276.5317.1423","article-title":"Hyperplasia of lymphatic vessels in VEGF-C transgenic mice","volume":"276","author":"Jeltsch","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.lungcan.2004.02.021_BIB4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.RES.0000073584.46059.E3","article-title":"VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses","volume":"92","author":"Rissanen","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB5","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1101\/gad.13.9.1055","article-title":"Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development","volume":"13","author":"Gale","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB6","first-page":"2431","article-title":"Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma","volume":"6","author":"Niki","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB8","first-page":"861","article-title":"Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma","volume":"3","author":"Fontanini","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB9","first-page":"1483","article-title":"Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma","volume":"4","author":"Shibusa","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB10","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1054\/bjoc.1999.1129","article-title":"Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer","volume":"82","author":"O\u2019Byrne","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lungcan.2004.02.021_BIB11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10434-001-0072-y","article-title":"Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis","volume":"8","author":"Han","year":"2001","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB12","first-page":"1807","article-title":"Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma","volume":"3","author":"Tsao","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<369::AID-PATH381>3.0.CO;2-X","article-title":"Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1\/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival","volume":"188","author":"Decaussin","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB14","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0002-9440(10)64828-6","article-title":"Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor\/vascular permeability factor by human lung cancer cells","volume":"157","author":"Yano","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB15","first-page":"2652","article-title":"Significant expression of vascular endothelial growth factor\/vascular permeability factor in mouse ascites tumors","volume":"58","author":"Luo","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/jnci\/90.6.447","article-title":"Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice","volume":"90","author":"Yoneda","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/84643","article-title":"Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis","volume":"7","author":"Skobe","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB18","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/ijc.10283","article-title":"VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors","volume":"98","author":"Mattila","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lungcan.2004.02.021_BIB19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/84635","article-title":"VEGF-D promotes the metastatic spread of tumor cells via the lymphatics","volume":"7","author":"Stacker","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB20","first-page":"419","article-title":"Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice","volume":"20","author":"Yanai","year":"2001","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jjco\/hyg008","article-title":"Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma","volume":"33","author":"Ishikawa","year":"2003","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1368-8375(02)00143-4","article-title":"Expression of vascular endothelial growth factor-C predicts regional lymph node metastasis in early oral squamous cell carcinoma","volume":"39","author":"Kishimoto","year":"2003","journal-title":"Oral Oncol."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1054\/bjoc.2001.1882","article-title":"The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer","volume":"85","author":"Kajita","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lungcan.2004.02.021_BIB24","first-page":"1669","article-title":"Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma","volume":"62","author":"White","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB25","first-page":"1361","article-title":"Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma","volume":"9","author":"Yokoyama","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/cncr.11073","article-title":"Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma","volume":"97","author":"Arinaga","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2004.02.021_BIB27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.bjc.6600701","article-title":"Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma","volume":"88","author":"Yokoyama","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lungcan.2004.02.021_BIB28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000070301","article-title":"Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma","volume":"64","author":"Funaki","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/j.lungcan.2004.02.021_BIB29","first-page":"957","article-title":"Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation","volume":"6","author":"Yano","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB30","first-page":"499","article-title":"Biological characteristics of carcinomatosa pleuritis in orthotopic model systems using immune-defficient rats","volume":"18","author":"Ohta","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1568011033353452","article-title":"Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy","volume":"3","author":"Shinkaruk","year":"2003","journal-title":"Curr. Med. Chem. Anti-Cancer Agents"},{"key":"10.1016\/j.lungcan.2004.02.021_BIB32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1023\/A:1006358220123","article-title":"Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors","volume":"18","author":"Schlaeppi","year":"1999","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB33","first-page":"41","article-title":"Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy","volume":"60","author":"Wood","year":"2000","journal-title":"Medicina"},{"key":"10.1016\/j.lungcan.2004.02.021_BIB34","first-page":"2594","article-title":"Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor\/permeability factor neutralizing antibody","volume":"58","author":"Luo","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB35","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0002-9440(10)64467-7","article-title":"Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer","volume":"161","author":"Hu","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1021540120521","article-title":"A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR\/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model","volume":"5","author":"Zhang","year":"2002","journal-title":"Angiogenesis"},{"key":"10.1016\/j.lungcan.2004.02.021_BIB37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.cgt.7700428","article-title":"VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice","volume":"9","author":"Kamiyama","year":"2002","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB38","first-page":"622","article-title":"Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line","volume":"6","author":"Kondo","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB39","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1349-7006.2002.tb01302.x","article-title":"Expression of vascular endothelial growth factor and E-cadherin in human ovarian cancer: association with ascites fluid accumulation and peritoneal dissemination in mouse ascites model","volume":"93","author":"Akutagawa","year":"2002","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB40","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1006\/bbrc.1996.0507","article-title":"Characterization of the murine VEGF-related factor gene","volume":"220","author":"Townson","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1006\/geno.1997.4774","article-title":"Molecular cloning of a novel vascular endothelial growth factor, VEGF-D","volume":"42","author":"Yamada","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.lungcan.2004.02.021_BIB42","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1210\/en.2002-0146","article-title":"Mouse endocrine gland-derived vascular endothelial growth factor: a distinct expression pattern from its human ortholog suggests different roles as a regulator of organ-specific angiogenesis","volume":"144","author":"LeCouter","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.lungcan.2004.02.021_BIB43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0002-9440(10)64181-8","article-title":"Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma","volume":"161","author":"Yazawa","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1096-9896(199901)187:2<191::AID-PATH206>3.0.CO;2-3","article-title":"Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer","volume":"187","author":"Yazawa","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","article-title":"Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma","volume":"324","author":"Weidner","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB46","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0003-4975(99)01579-9","article-title":"Clinicopathological and biological assessment of lung cancers with pleural dissemination","volume":"69","author":"Ohta","year":"2000","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00063198-200207000-00009","article-title":"Vascular endothelial growth factor: the key mediator in pleural effusion formation","volume":"8","author":"Grove","year":"2002","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB48","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/emboj\/20.4.672","article-title":"Vascular endothelial growth factor-C mediated lymphangiogenesis promotes tumour metastasis","volume":"20","author":"Mandriota","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB49","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jnci\/94.11.819","article-title":"Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling","volume":"94","author":"He","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB50","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0002-9440(10)65392-8","article-title":"VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer","volume":"154","author":"Valtola","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lungcan.2004.02.021_BIB51","first-page":"713","article-title":"Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats","volume":"63","author":"Krishnan","year":"2003","journal-title":"Cancer Res."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500204001096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500204001096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T03:55:57Z","timestamp":1549511757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500204001096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0169500204001096"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2004.02.021","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}